Psychiatric illness does not exist in isolation, and concomitant disorders such as dyslipidemia and glucose irregularities must be taken into account when viewing the whole clinical picture. Therefore ...

Pharmacogenetic testing, which is used to classify how patients with major depressive disorder (MDD) metabolize medications, reduces adverse drug-gene interactions, new research shows. In a randomized ...

Polypharmacy in RA patients is linked to increased drug interaction risks, especially with immunosuppressants, necessitating careful management and monitoring. Older age and multiple comorbidities are ...